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Abstract
Background—Pulmonary artery acceleration time (PAAT) is a non-invasive method to assess 
pulmonary hemodynamics, but lacks validity in children. This study sought to evaluate the 
accuracy of Doppler echocardiography (DE) derived PAAT in predicting right heart catheterization 
(RHC) derived pulmonary arterial pressure (PAP), pulmonary vascular resistance (PVR) and 
compliance in children.
Methods—Prospectively acquired and retrospectively measured DE derived PAAT and RHC 
derived systolic PAP (sPAP), mean PAP (mPAP), index PVR (PVRi) and compliance were 
compared by regression analysis in a derivation cohort of 75 children (median age, 5.3 years; 1.3–
12.6) with wide ranges of pulmonary hemodynamics. To account for heart rate variability, PAAT 
was adjusted for right ventricle ejection time (RVET) and corrected by the RR interval. Regression 
equations incorporating PAAT and PAAT:RVET from the derivation cohort were then evaluated for 
the accuracy of its predictive values for invasive pulmonary hemodynamics in a validation cohort 
of 50 age- and weight- matched children with elevated PAP and PVR.
Results—There were significant inverse correlations between PAAT and RHC derived mPAP (r = 
−0.82) and PVRi (r= −0.78) and direct correlation (r= 0.78) between PAAT and pulmonary 
compliance in the derivation cohort. For detection of pulmonary hypertension (PRVi > 3 WU x m2 
and mPAP > 25 mmHg), PAAT < 90 msec and PAAT:RVET < 0.31 resulted in a sensitivity of 97% 
and a specificity of 95%. In the derivation cohort, the regression equations relating PAAT with 
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mPAP and PVRi were: mPAP = 48 – 0.28 x PAAT and PVRi = 9 –0.07 x PAAT. These PAAT 
integrated equations predicted RHC measured pulmonary hemodynamics in the validation cohort 
with good correlations (r = 0.88, 0.83 respectively), small biases (<10%), and minimal coefficient 
of variation (<8%).
Conclusions—PAAT inversely correlates with RHC measured pulmonary hemodynamics and 
directly correlates with pulmonary arterial compliance in children. The study established PAAT 
based regression equations in children to accurately predict RHC derived PAP and PVR.
Keywords
Pulmonary artery acceleration time; pulmonary hypertension; pediatrics; echocardiography
INTRODUCTION
The assessment of pulmonary hemodynamics is critical in the diagnosis and management of 
cardiopulmonary diseases in children.1–3 Right heart catheterization (RHC) remains the gold 
standard investigation for determining pulmonary vascular resistance (PVR) and pulmonary 
artery pressures (PAP).1–5 However, the increased risk of an invasive procedure 
accompanied with radiation exposure and the frequent need for general anesthesia makes the 
RHC use as a screening or monitoring tool in children with significant cardiopulmonary 
disease problematic.1,6,7 Doppler echocardiography (DE) is widely used in clinical practice 
as a surrogate for RHC for PAP quantification using the maximum Doppler velocity of 
tricuspid regurgitation. However, recent studies in children and adults comparing Doppler 
velocity of tricuspid regurgitation and RHC methods have revealed clinically relevant 
discrepancies between Doppler-estimated and catheter measured PAP.1,8–10 This problem is 
compounded by the fact that in significant number of children the Doppler velocity of 
tricuspid regurgitation is either absent or insufficient to measure.1–3,8–10
There is a clinical need for a noninvasive method, other than Doppler velocity of tricuspid 
regurgitation, to accurately predict PAP, PVR, and pulmonary arterial compliance in 
children. Pulmonary artery acceleration time (PAAT) is a quantitative method used to study 
the blood flow velocity characteristics in the RV outflow tract (RVOT) in response to 
changes in ventricular mechanical performance and pulmonary vascular load and 
compliance.4,5,11,12 A number of adult studies have shown a strong, inverse correlation 
between PAAT and invasively measured pulmonary hemodynamics3–5,12–14 but there are 
limited studies in children.2,11,15–18 Currently, PAAT is not used clinically to evaluate 
pulmonary hemodynamics in pediatric patients because its validity in children has not been 
demonstrated.
We hypothesized that PAAT would accurately predict RHC measured pulmonary 
hemodynamics in pediatric patients. The aim of this study was to evaluate the correlations of 
DE measured PAAT with RHC derived PAP and PVR in children to establish and validate 
regression equations that utilize PAAT to estimate these invasive measurements.
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METHODS
Study Design
In this study, we performed pulmonary hemodynamic assessment by DE and RHC in two 
cohorts of pediatric patients: (1) A derivation cohort to assess the correlations between DE 
measured PAAT and RHC measured PAP for the establishment of PAAT based regression 
equations, and (2) A validation cohort to substantiate these PAAT based regression equation 
for their accuracy in predicting invasive measured pulmonary hemodynamics. In each 
cohort, DE and RHC were performed both simultaneously under the same loading and 
sedation conditions, as well as non-simultaneously to represent typical clinical condition in 
both cohorts.
Derivation Cohort
The derivation cohort consisted of 75 children (ages 1 to 18 years) who presented to the 
Saint Louis Children’s Hospital (Missouri, USA) cardiac catheterization laboratory for 
clinically indicated RHC between November 2011 and December 2013. DE and RHC were 
performed simultaneously (n=50 children) or within six hours (n=25 children) of each other 
(DE followed by RHC). The data was prospectively acquired and retrospectively analyzed. 
The 50 children who underwent simultaneous DE and RHC were recruited from a previous 
study reported by our group,1 in whom the invasive pulmonary hemodynamics and PAAT 
were not reported. Children included in the study had wide range of right heart pressures and 
diagnoses including pulmonary arterial hypertension due to idiopathic, heritable, or 
connective tissue diseases etiology, lesions with left-to-right shunt, and orthotopic heart 
transplant (OHT), representing the spectrum of cardio-pulmonary diseases seen in clinical 
practice (Table 1). Children with single ventricle physiology, a mechanical tricuspid valve, 
RVOT obstruction, left heart diseases, arrhythmias, pulmonary insufficiency, or on 
pulmonary vasodilators were excluded.1 Informed, written parental consent was obtained for 
all subjects and assent was obtained for all subjects >12 years of age. The institutional 
review board at Washington University School of Medicine approved all components of the 
study.
Right Heart Catheterization
Fifty children underwent simultaneous DE and RHC in the cardiac catheterization laboratory 
under the same sedation and loading conditions and 25 children had the DE performed first 
without sedation, followed by a sedated RHC within six hours. RHC measured mean PAP 
(mPAP) and systolic PA (sPAP) using a standard fluid filled catheter. An interventional 
cardiologist, blinded to the patients’ diagnoses and echocardiographic data, analyzed 
pressure tracings to evaluate pulmonary hemodynamics. Cardiac output (CO) and pulmonary 
blood flow (Qp) were calculated using standard Fick’s method and indexed to body surface 
area (Qpi). Pulmonary artery compliance (ml/mmHg/m2) was calculated as the ratio of 
stroke volume (Qpi divided by heart rate) to pulmonary artery pulse pressure. PVR (WU) 
indexed to body surface area (PVRi, WU x m2) was derived using pulmonary capillary 
wedge pressure (PCWP) from the following equation: (mPAP - PCWP)/Qpi. Oxygen 
consumption was assumed using standard LaFarge’s methodology.19
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Echocardiography
We acquired two-dimensional and color DE images of the parasternal and apical standard 
views with the patient in the supine position per the American Society of Echocardiography 
guidelines.20 We developed a protocol for PAAT image acquisition and post-processing data 
analysis (Appendix 1) and tested for variability using reproducibility statistical analysis.21 A 
spectral Doppler image was obtained by placing a pulsed Doppler sample volume at the 
pulmonary valve annulus in the parasternal short-axis view (Figure 1). Maximal alignment 
of Doppler interrogation with blood flow direction was achieved with the placement of the 
sample volume at the annulus of the pulmonary valve and not more proximally in the RVOT. 
PAAT was calculated from a spectral Doppler envelope as the time interval between the on\ 
set of systolic pulmonary arterial flow (onset of ejection) and peak flow velocity (Figure 1).
Confounding Influences
The variables confounding the PAAT measures include imaging acquisition techniques and 
postprocessing analysis, heart rate variability, influence of right ventricular mechanics and 
function, and pulmonary compliance.11,22 We identified and quantified the image acquisition 
and post process analysis uncertainties with the development of a protocol (Appendix 1). To 
account for the potential impact of heart rate variability PAAT was corrected for the R-R 
interval (PAATc) and also adjusted for right ventricle ejection time (RVET) with a ratio of 
PAAT:RVET.12,16,23,24 The mean PAAT:RVET ratio from three cardiac cycles were used for 
data analysis and further corrected by the square root of the R-R interval (PAAT:RVETc).24 
PAAT:RVET and the R-R interval were compared with a linear regression. We measured RV 
pre-ejection time, RVET, and the ratio of RV pre-ejection time to RVET (PET:RVET) to 
assess RV mechanics.25 Pre-ejection time was defined as the interval between the onset of 
QRS complex to the onset of RV ejection, whereas RVET is defined as the interval between 
the onset of RV ejection to the cessation of systolic pulmonary arterial flow in the same 
cardiac cycle (Figure 1).6,12
We assessed RV function by two dimensional speckling tracking echocardiography derived 
global longitudinal systolic strain, a sensitive and reliable measure with published normative 
values in children.26 One sonographer measured RV global longitudinal strain in the 
children who had simultaneous DE and RHC using a protocol previously validated by our 
group and others.21
PAAT based Regression Equations and Cut-Off Values
In the derivation cohort, PAAT and PAAT:RVET were compared with RHC derived mPAP, 
sPAP, PVR, and PVRi by both linear and logarithmic regression analysis, (P value < 0.01 
was considered significant). A receiver operating characteristic (ROC) curve was 
constructed to determine a cut-off value for PAAT and PAAT:RVET with the best sensitivity 
to predict pulmonary hypertension defined as elevated PVR values > 2 WU and PVRi > 3 
WU x m2, elevated sPAP > 30mmHg, and mPAP > 25 mmHg.27 The statistical analysis was 
performed using SPSS version 14.0 (SPSS, Inc., Chicago, IL).
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Validation Cohort
The regression equations utilizing PAAT and PAAT:RVET that were generated in the 
derivation cohort to predict PAP and PVR were subsequently validated in two separate 
validation sub-cohorts: (1) 25 age- and gender-matched pediatric patients with a wide range 
of pulmonary hemodynamics who were prospectively recruited and underwent simultaneous 
RHC and DE between January 2014 and December 2014; and (2) 25 age- and gender-
matched pediatric patients with pulmonary arterial hypertension who had DE and RHC 
within seven days of each other were identified from retrospective search of the database for 
the period between November 2011 and December 2013. We included this retrospective 
validation sub-cohort to demonstrate the applicability of the PAAT based regression 
equations in routine clinical practice under no sedation. We assessed the predictive value of 
the PAAT based regression equations to estimate PAP and PVR in both validation sub-
cohorts, by comparing to the RHC derived pulmonary hemodynamics with 1) Bland-Altman 
plot analysis (percentage bias and 95% limits of agreement, LOA), 2) intraclass correlation, 
ICC, and 3) coefficient of variation, CV. A bias < 10%, narrow 95% LOA, a CV < 10%, and 
an ICC > 0.8 were recognized as measures of minimal variability and positive reliability.21
Reproducibility Analysis
Reproducibility of PAAT measurements was assessed using intra- and inter-observer 
variability in 60% of the images from the derivation and validation cohorts. Three observers 
(P.T.L., M.D.P. and G.K.S.) performed offline analysis using the same measurement protocol 
and were blinded to the patients’ diagnoses, RHC data and each other (Appendix 1).
RESULTS
Baseline Patient Characteristics
A total of 125 patients with a wide range of pulmonary hemodynamics were included in this 
study; 75 children in the derivation cohort and 50 children in the validation cohort. PAAT 
measurements were feasible with high degree of reproducibility in all children (Appendix 2). 
Patients’ demographic, cardio-pulmonary diagnosis and baseline hemodynamic data are 
summarized in Table 1. In the overall cohort, mPAP ranged widely from 12 mmHg to 60 
mmHg, PVR ranged from 2 Woods Units (WU) to 10.4 WU, PVRi ranged from 2 WU x m2 
to 18 WU x m2. (PCWPs were within normal limits, ranging from 3 mmHg to 9 mmHg; 
none of the patients had altered pulmonary hemodynamics from left heart disease).
RHC derived Pulmonary Hemodynamics and PAAT
Table 2 shows group mean values and ranges for RHC derived pulmonary hemodynamic 
data and DE derived PAAT data for the derivation and validation cohorts. Figure 2 
summarizes the correlation between the RHC derived PAP and PVR with the PAAT by 
regression analysis.
Systolic Pulmonary Artery Pressure—Linear regression analysis between PAAT and 
PAAT:RVET and sPAP demonstrated inverse correlations for both in all patients (r= −0.78, 
−0.80; p < 0.001). The relationship between log10 (sPAP) and PAAT and PAAT:RVET 
slightly increased the correlation (r= −0.79, r= −0.82, respectively). Patients with sPAP ≥30 
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mmHg had significantly lower values of PAAT (65 ± 16 vs. 105 ± 20 ms, p<0.001) and 
PAAT:RVET (0.25 ± 0.05 vs. 0.37 ± 0.06, p<0.01) than those with <30 mmHg. The 
regression equation relating sPAP and PAAT from our derivation cohort data set is: sPAP = 
64 – 0.39 x PAAT.
Mean Pulmonary Artery Pressure—Linear regression analysis between PAAT and 
PAAT:RVET with mPAP, demonstrated robust inverse correlations for both in all patients (r= 
−0.82, −0.81; p < 0.001). The relationship between log10 (mPAP) and PAAT or PAAT:RVET 
slightly increased the correlation (r= −0.83; r= −0.83, respectively). Patients with mPAP ≥25 
mmHg had significantly lower values of PAAT (58 ± 11 vs. 100 ± 23 ms, p < 0.001) and 
PAAT:RVET (0.36 ± 0.07 vs. 0.23 ± 0.04, p < 0.01) than those with < 25 mmHg. The 
regression equation relating mPAP and PAAT from our derivation cohort data set is: mPAP = 
48 – 0.28 x PAAT.
Pulmonary Vascular Resistance—There were good inverse correlations of PAAT and 
PAAT:RVET with PVR for all patients (r= −0.82, −0.79, p < 0.001). The correlations were 
similar when PVRi was used in place of PVR (r= −0.78, r= −0.78, respectively). The 
relationship between log10 (PVR) and log10 (PVRI) with PAAT and PAAT:RVET slightly 
increase the correlation (r= −0.85, −0.81, −0.81, −0.80) respectively). Patients with PVRi > 
3 WU x m2 had significantly lower values of PAAT (68 ± 17 vs. 98 ± 24 ms, p<0.001) and 
PAAT:RVET (0.28 ± 0.05 vs. 0.35 ± 0.07, p<0.01) than those with ≤ 3 WU x m2. The 
regression equations relating PVR and PVRi to PAAT from our derivation cohort data set 
are: PVR = 12 – 0.1 x PAAT and PVRi = 9 – 0.07 x PAAT, respectively.
Predictive Values of PAAT and PAAT:RVET for Pulmonary Hemodynamics
ROC curve analysis was used to determine specific cut-off values of PAAT and PAAT:RVET 
in predicting elevated pulmonary hemodynamics (Figure 3). For detection of PVR > 2 WU, 
PVRi > 3 WU x m2 mPAP > 25 mmHg, and sPAP > 30 mmHg, a PAAT < 90 msec resulted 
in a sensitivity of 97% and a specificity of 95% with an area under ROC curve (AUC) of 
0.98 (0.94 – 0.99, 95% CI). PAAT:RVET < 0.31 resulted in a sensitivity 87% and a 
specificity of 89% with an AUC of 0.92 (0.84 – 0.99, 95% CI). Only three patients (2%) 
were misclassified as normal (n=2) or abnormal (n=1) using the cut-off values. There was no 
common link in diagnosis or patient characteristics for these patients. For patients with a 
diagnosis of pulmonary arterial hypertension (n=32, a PVR > 3 WU, mPAP ≥ 25 mmHg, 
and sPAP > 30 mmHg), a PAAT < 88 msec and PAAT:RVET < 0.30 had a sensitivity 96% 
and a specificity of 95% with an AUC of 0.92 (0.89 – 0.97, 95% CI). The positive and 
negative predictive values for elevated PVRi > 3 WU x m2 based on the cut-off value of 
PAAT < 90 msec was 86% and 82% respectively. RV strain was significantly decreased in 
patients with PAAT < 90 msec and PAAT:RVET < 0.31 (−15.8 ± 4.5 vs. −20.2 ± 4.4, p 
<0.001).
Validation of Regression Equations
The estimated pulmonary hemodynamic values derived from the PAAT integrated regression 
equations from the derivation cohort when compared to the RHC derived pulmonary 
hemodynamics in the validation cohort yielded strong correlation, small biases < 10%, 
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narrow LOA, intraclass correlation > 0.8, and coefficient of variation < 10% in both 
validation cohorts (Table 3). There was minimal variation in analysis when gender, age, 
blood pressure, and body surface area were included in the regression plots. The 
comparisons were significantly less reliable at the extreme values of PAAT, as expected.5 
With ROC curve analysis, a PAAT < 40 msec and a PAAT:RVET < 0.23 detected PVR > 8 
WU, PVRi > 10 WU x m2, mPAP > 45 and sPAP > 65 mmHg with a sensitivity of 93% and 
specificity of 92%. Values of PAAT and PAAT:RVET lower than these thresholds were 
unpredictable, despite correction with logarithmic regression.
Cofounding Influences on PAAT
There was no statistically significant correlation between PAAT:RVET ratio and R-R interval 
(r=0.004). Consequently, both PAAT and the ratio of PAAT:RVET were not corrected for R-
R interval in the analysis. Pulmonary artery compliance ranged from 0.61 to 4.01 ml/
mmHG/m2 in the cohort (Table 2). There were good linear correlations between PAAT and 
PAAT:RVET with PA compliance for all patients (r= 0.78, r= 0.75, respectively, p < 0.01). 
RV global longitudinal strain ranged from −8% to −28% and there were good linear 
correlations between PAAT and PAAT:RVET with RV strain (r = −0.85 and r =−0.82, 
respectively). A PAAT < 90 msec and PAAT:RVET < 0.31, detected a cut-off value of RV 
global longitudinal strain −16 % with a sensitivity of 86% and a specificity of 86% with an 
AUC of 0.83 (0.79– 0.97, 95% CI). Children with RV strain values less than −16%, had 
longer pre-ejection time (95 ± 15 msec vs. 60 ± 12 msec, p < 0.01) and increased ratio of 
Pre-ejection time:RVET (0.31 vs. 0.25, p < 0.01) indicative of longer time required by RV to 
develop wall tension to overcome the afterload. Because of the linear inter-dependence of 
PAAT measures with RV strain and PA compliance and in the same direction, both were not 
taken in account in analysis of PAAT and PAAT:RVET with pulmonary hemodynamics.
DISCUSSION
This study presents DE derived PAAT as a TR-independent reliable measure of pulmonary 
hemodynamics in children. It defines a quantitative relationship between PAAT and RHC-
derived pulmonary hemodynamics and shows that (1) PAAT is easily obtainable and 
reproducible in children, (2) PAAT inversely correlates with RHC derived pulmonary arterial 
pressures and vascular resistance and directly correlates with pulmonary arterial compliance, 
and (3) PAAT based regression equations reliably predict a wide range of RHC derived 
pulmonary hemodynamics. The novel finding derived from the quantitative relationship 
between PAAT and invasive pulmonary hemodynamics demonstrate that a shorter PAAT of 
<90 msec and PAAT:RVET < 0.31 reliably detect the triad of elevated PVR, decreased 
pulmonary arterial compliance, and RV dysfunction with high degree of sensitivity and 
specificity in children.
Our study reveals that PAAT is a comprehensive quantitative index of pulmonary 
hemodynamics in children and represents the result of a dynamic interaction between RV 
mechanical performance and pulmonary vascular load and arterial compliance in children.28 
PAAT predictably shortens with increasing PVR and the degree of shortening is inversely 
related to the magnitude of the PVR that holds over a wide range of resistances. When PAAT 
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is modified to take into account heart rate (PAAT:RVET) the correlation is further enhanced. 
Thus, a PAAT of < 90 msec and PAAT:RVET < 0.31 detected patients with pulmonary 
hypertension (a PVRi > 3 WU x m2 and a mPAP > 25 mmHg) with high degree of 
sensitivity and specificity. However, PVR alone does not represent the total afterload to the 
RV, because it does not take into account the “impedance” to the forward pulsatile blood 
flow from backward pressure wave reflections from multiple bifurcations of the pulmonary 
circulation.29 In pulmonary vascular disease the noncompliant nature of the distal vascular 
bed causes impedance to increase and forward blood flow to decelerate early in systole as 
the reflected pressure wave front reaches the pulmonary trunk prematurely, causing an early 
systolic deceleration and early peaking of flow velocity in in the pulmonary artery. 
Therefore, the time to peak velocity in the pulmonary artery decreases and PAAT shortens 
(Figure 1b).30
The degree of arterial wave reflection is not only determined by vascular resistance, but 
predominantly by large and medium vessel stiffness, and the geometry of the pulmonary 
vasculature.31 In this study, the children with low pulmonary arterial compliance (as 
measured by the ratio of stroke volume/PA pulse pressure) also demonstrated a shortening of 
the PAAT. This suggests that PAAT integrates the pulsatile phenomena of pulse wave 
propagation causing “impedance.” Thus, PAAT shortening may indicate the presence of an 
underlying pulmonary arterial disease in children.
We further observed that children with a cutoff value of PAAT < 90 msec had decreased RV 
strain values, suggesting that shorter PAAT is also associated with differing degrees of RV 
dysfunction in patients with pulmonary hypertension, which parallels the relationship of 
PAAT with PVR and pulmonary arterial compliance. This implies that RV afterload is a 
major contributor to the observed differences in RV function.32 Intuitively, the development 
of significant decreased RV function might lead to a slower rise in ejection velocities early 
in systole and a longer PAAT. However, in the setting of depressed RV function and elevated 
pulmonary vascular resistance, we observed a longer pre-ejection time and ratio of pre-
ejection time to RVET that reflects the increased time needed by the RV to develop the wall 
tension necessary to overcome the elevated afterload. This suggests that the impaired 
ventricular contraction alone might not cause an early deceleration of pulmonary systolic 
flow if the pulmonary vascular bed is normal.30 The combined effect of depressed RV 
function, altered pulmonary hemodynamics, and decreased vascular compliance leads to 
increased pre-ejection time (elevated ratio of PET:RVET) and a shorter PAAT.25
This is the first study in children, to our knowledge, depicting the novel finding of shorter 
PAAT association with the triad of elevated PVR, decreased pulmonary arterial compliance, 
and RV dysfunction. PAAT represents the interactive changes in ventricular mechanical 
performance, pulmonary vascular load and compliance in children.
PAAT Derived Equations of Pulmonary Hemodynamics
Studies in children have previously evaluated PAAT as an echocardiographic measure of 
PAP, but with inconsistent results and lack of obvious reliable “cut-off” values to establish 
sensitive interrelation between DE derived PAAT and RHC derived pulmonary 
hemodynamics.2,11,15–18 Kosturakis et al. demonstrated PAAT as a discriminator between 
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patients with elevated PAP and normal PAP; with PAAT showing moderate inverse 
correlation with elevated PAP (r = −0.62).16 However, Ebeid et al. 15 showed less robust 
correlation (r ranged from −0.41 to −0.7), and Cooper et al.18 showed no correlation 
between PAAT and invasive pulmonary hemodynamic measures in children with ASD or a 
VSD. Cevik et al. performed DE and RHC in children and described PAAT(c) cut-off values 
of 124 msec that identified children with pulmonary arterial hypertension (with a sensitivity 
of 79% and specificity of 73%).2 These studies consisted of small patient cohorts, were 
performed under differing loading conditions between the measurements of PAAT and RHC 
measurements of pulmonary hemodynamics, and did not perform reproducibility analysis. In 
comparison, our study established and validated, with multiple and consistent reliability tests 
(separate derivation and validation cohorts) “cutoff values” of PAAT and PAAT:RVET to 
predict elevated pulmonary hemodynamics with high levels of sensitivity and specificity that 
were lacking in previous studies in children. This is also the first study in children to 
describe regression equations that utilized PAAT to estimate PVR and PVRi.
Extremes of PAAT
We observed a deviation from the straight line in points with extremely high PAP and PVR, 
with the curve resembling a logarithmic function (Figures 2).2,5 It appears that the 
relationship between PAAT and pulmonary hemodynamics may be curvilinear at the 
extremes.30 We therefore performed logarithmic transformation of each pulmonary 
hemodynamic derived measure and found only slight improvement in correlation with PAAT 
and PAAT:RVET. Similar to Kitabatake et al. and Cevik et al, we feel that the both the linear 
and logarithmic regression equations will not accurately predict the exact invasive 
pulmonary hemodynamic values with extremely low PAAT.2,5 Even when the correlation 
coefficients are reasonable (>0.8), there is enough scatter in the plots in this study and 
previous studies to preclude confidence in the accuracy of results at the extremes. Moreover, 
the scatter is largest at the highest pulmonary pressures and resistance, where prediction 
matters most. To account for this limitation, we subsequently used ROC analysis to 
determine that a PAAT value less than 40 ms or a PAAT:RVET less than 0.23 predicted a 
mPAP > 45 mmHg and a PVRi > 9. Although the PAAT based regression equations cannot 
precisely predict the invasive measures at the extremes, we have demonstrated that a novel 
clinically relevant “cut-off value” can be used instead to detect markedly elevated pulmonary 
hemodynamic measures.
Influence of heart rate
We assessed the impact of the heart rate on PAAT measures by adjusting the PAAT by the 
RVET and correlating each by the R-R interval. We plotted the R-R interval against the 
PAAT:RVET. Similar to Subhedar et al.33 and Fitzgerald and Evans22, we did not 
demonstrate a statistically significant correlation between these variables and concluded that 
inclusion of the corrected ratio was considered unnecessary. As the HR increases, both 
PAAT and RVET may shorten, and PAAT may underestimate PVR and PAP. However, 
Kosturakis et al observed that although RVET and PAAT decrease with increasing heart rate, 
the ratio of PAAT:RVET was uninfluenced by heart rate.16 Other studies have shown that for 
a heart rate less than 60 or greater than 100, the PAAT needed to be corrected for heart rate 
to improve correlation.4–6,12,23 We adjusted for the heart rate with the ratio of PAAT:RVET, 
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and validated equations that showed good relationships with PAP and PVR in children with 
heart rates that range between 55 and 150.
Clinical Implications
The assessment of pulmonary hemodynamics includes evaluation of both pressure and 
resistance. The echocardiographic assessment of pulmonary hypertension in adults, children, 
and even preterm infants with chronic lung disease often begins with evaluation of the 
presence of the Doppler velocity of tricuspid regurgitation. Doppler velocity of tricuspid 
regurgitation, when present, is advantageous in certain clinical situations (i.e. in children 
with large intracardiac left to right shunts), however “a method which allows data collection 
in only a minority of subjects may not be the best for describing physiological and 
pathological changes.”34 Furthermore, in the absence of a high quality Doppler velocity of 
tricuspid regurgitation, the ability to quantitatively assess PAP and PVR (using the Abbas 
equation35) non-invasively is limited. PAAT measures have been reported in adults and 
children in multiple studies, but by properly validating a quantitative relationship between 
PAAT and RHC derived pulmonary hemodynamic parameters in both simultaneous and 
clinically relevant situations, our study provides a clinically applicable non-invasive 
screening tool to estimate both PAP and PVR in children with a wide range of pulmonary 
hemodynamics. We observed that a PAAT < 90 msec and PAAT:RVET < 0.31 would 
identify most patients with mPAP > 25 and PVRi > 3 WU x m2 in different clinical 
scenarios in children, and is similar to published results in adults.2,6,14,36 PAAT is not meant 
to replace invasive catheterization as the standard reference method, but it offers an effective 
screening tool for pediatric patients on whom to select for invasive assessment, or be an 
alternative monitoring tool in patients who cannot undergo catheterization because of their 
clinical condition, and should be considered when Doppler velocity tricuspid regurgitation is 
absent.37
Strengths and Limitations
Several factors may affect the duration of the PAAT and lead to inaccurate values, including 
heart rate, cardiac output, RV function, and imaging technique. To account for the variations 
we developed a protocol to acquire and analyze PAAT that will improve its reliability in 
children across a diverse range of disease states. PAAT measures most likely differ in the 
presence of significant intra-cardiac left to right shunts.15 In our study 20 patients (13%) had 
an ASD, but its presence did not appear to affect the duration of the PAAT when accounted 
for in the analysis. However, this study was not powered to account for the impact of an 
ASD on PAAT, and the true influence of shunts is an area for further investigation.34 We 
elected to use RV strain as a measure of RV function, but future work should assess the 
relationship between other measures of RV function (i.e. tricuspid annular plane systolic 
excursion, fractional area of change, dP/dt) and PAAT measures.
The derivation and validation cohorts intentionally included a heterogeneous patient 
population with several different diagnoses. The PAAT based regression equations were 
validated with simultaneous and non-simultaneous DE and RHC so that they would account 
for and be applicable across a wide range of abnormal pulmonary hemodynamics and 
loading conditions in clinical pediatric practice, a fact that sets this study apart from 
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previous work and further validates the relationships. The inclusion of heart transplant 
patients introduced a separate potential bias, as these patients typically have sutures at the 
anastomosis of the recipient with donor pulmonary arteries that influence PA compliance. 
However, the regression equation held their validity, and PAAT was not affected by discrete 
stiffening of the main pulmonary artery at the site of anastomosis.
CONCLUSIONS
PAAT is feasible in children and inversely correlates with RHC derived pulmonary 
hemodynamics. The study establishes and validates PAAT based regression equations in 
children to estimate RHC derived sPAP, mPAP, PVR, and PVRi. These predictive 
relationships permit PAAT to be considered as a noninvasive tool for reliably estimating and 
monitoring pulmonary hemodynamics in children.
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Appendix 1: Protocol for Pulmonary Artery Acceleration Time Image 
Acquisition and Postprocessing Data Analysis
Measurements: Pulmonary artery acceleration time and right ventricle ejection time
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A) Optimize image acquisition
• Mode: Fundamental imaging mode. Center frequency of 4–12 MHz. Two-
dimensional grey scale images acquired.
• Views: Pulsed-wave Doppler interrogation of the proximal pulmonary artery was 
performed in the parasternal short-axis view (Figure 1) as proposed by the 
American Society of Echocardiography.
• A spectral Doppler image obtained by placing a pulsed Doppler sample volume 
at the pulmonary valve annulus. The sample volume was placed at the annulus of 
the pulmonary valve and not more proximally in the RV outflow tract to 
maximally align blood flow and Doppler interrogation.
• ECG tracing on screen – minimize artifacts.
• Store/Record: Three consecutive cardiac cycles. A minimum of three Doppler 
spectral flow velocity envelopes is stored for analysis to account for respiratory 
variation.
• Morphology: The Doppler spectral flow velocity envelope needs to meet three 
criterion to be considered acceptable for analysis: (1) Clear onset of the Doppler 
spectral flow velocity envelope, (2) Clearly demarcated edges of the Doppler 
spectral flow velocity envelope avoiding modal frequency, and (3) Three 
consecutive well-defined Doppler spectral signals across the RVOT.
• Image archiving and storage: Store the two-dimensional cineloop images as 
enhanced DICOM digital loops for off-line analysis.
B) Pulmonary artery acceleration time analysis
• Pulmonary artery acceleration time (PAAT) and the right ventricle ejection time 
(RVET) are measured from each Doppler spectral flow velocity envelope. All the 
values used for analysis represent the average of three consecutive cardiac cycles 
to account for respiratory variation in pulmonary flow.
• PAAT is calculated from the spectral Doppler image at the pulmonary valve 
annulus. PAAT is defined as the interval between the onset of systolic pulmonary 
arterial flow (onset of ejection) and peak flow velocity (Figure 1).
• Right ventricle ejection time (RVET) is measured from the interval between the 
onset of RV ejection to the point of systolic pulmonary arterial flow cessation 
(Figure 1).
• The ratio of the PAAT to RVET is calculated by dividing the acceleration time by 
the right ventricular ejection time.
• The mean PAAT:RVET ratio from three waveforms was used for subsequent data 
analysis.
• Exclusion: Non-measurable Doppler signal across the right ventricle outflow 
tract by color Doppler at the time of data acquisition, or an inadequate Doppler 
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spectral flow velocity envelope that lacked the appropriate morphology, 
brightness, or sharply defined edges.
Appendix 2: Reproducibility Analysis
Bland Altman ICC CV Correlation
Bias (%) LOA Coefficient (95% CI) P value (%) R value P value
Intra- observer
 PAAT 4% −1.6 – 1.6 0.97 (0.94–0.98) 0.01 2.7% 0.97 0.001
 PAAT:RVET 5% −0.3 – 0.3 0.90 (0.84–0.94) 0.04 4.4% 0.92 0.04
Inter- observer
 PAAT 7% −4.8 – 4.7 0.93 (0.89–0.96) 0.03 3.9% 0.93 0.03
 PAAT:RVET 7% −0.3 – 0.5 0.90 (0.85–0.94) 0.04 4.5% 0.91 0.04
LOA, limits of agreement; Correlation, Pearson’s correlation
PAAT, Pulmonary acceleration time (msec)
RVET, Right ventricle ejection time (msec)
ICC, Intraclass correlation coefficient
CV, Coefficient of variation
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Figure 1. 
A) Pulmonary artery (PA) velocity curve in a patient with normal PA pressure. PA 
acceleration time (PAAT) is defined as the interval between the onset of systolic pulmonary 
arterial flow and peak flow velocity. Right ventricle ejection time (RVET) was measured 
from the interval between the onset of RV ejection to the point of systolic pulmonary arterial 
flow cessation. B) PA velocity curve with a shortened PAAT in a patient with high PA 
pressures. Ao, aorta; RPA, right pulmonary artery; LPA, left pulmonary artery
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Figure 2. 
Correlation plots between RHC derived pulmonary hemodynamics and pulmonary artery 
acceleration time; 2A) Systolic pulmonary artery pressure (sPAP); 2B) Mean pulmonary 
artery pressure (mPAP); 2C) Pulmonary vascular resistance (PVR); 2D) Pulmonary vascular 
resistance index (PVRi).
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Figure 3. 
Receiver operator curve analysis to determine specific cut-off values of PAAT in predicting 
altered pulmonary hemodynamics. For detection of PVR > 2 WU, PVRi > 3 WU x m2, 
mPAP ≥ 25 mmHg, and sPAP > 30 mmHg, PAAT < 90 msec resulted in a sensitivity of 97% 
and a specificity of 95%
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Table 1
Demographic and Clinical Characteristics of the Patients Undergoing Simultaneous and Non-Simultaneous 
Right Heart Catheterization and Doppler Echocardiography
Variable Study Cohort (n = 75) Validation Cohort (n = 50)
Age (years) 6.0 (1.4 – 14.2) 8.0 (1.2–14.3)
Female 46 (61%) 27 (54%)
Caucasian (%) 84 80
Weight (kg) 20 (11.4 – 48.2) 23 (13.9 – 65)
Body surface area (kg/m2) 0.70 (0.43 – 1.35) 0.83 (0.55 – 1.18)
Hemoglobin (mg/dL) 11.1 ± 1.6 11.0 ± 1.9
Heart rate (beats/minute) 104 ± 22 (53 – 155) 104 ± 19 (60 – 144)
Systolic blood pressure (mmHg)* 83 ± 15 (60 – 128) 84 ± 22 (54 – 141)
Diastolic blood pressure (mmHg)* 52 ± 11 (35 – 87) 55 ± 14 (30 – 90)
Mean arterial blood pressure (mmHg)* 63 ± 12 (44 – 103) 67 ± 15 (60 – 144)
Diagnosis
 Orthotopic heart transplantation 22 13
 Atrial septal defect 10 3
 Pulmonary artery hypertension 32 28
 Others 11 6
Reason for right heart catheterization
 Diagnostic 43 43
 Right ventricle biopsy 22 5
 Atrial septal defect device closure 6 1
 Others 4 1
Data are expressed as median (interquartile range) or mean ± SD (range) or numbers (percentage)
*Simultaneous systemic blood pressure was obtained by arterial catheterization in patients in whom arterial access was clinically indicated or by 
upper extremity noninvasive cuff measurement.
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Table 2
Measures of Pulmonary Hemodynamics
Variable
Derivation Cohort Validation Cohort
Simultaneous (n = 50)
Non-simultaneous (n = 
25) Simultaneous (n = 25)
Non-simultaneous (n = 
25)
RHC derived value
 Systolic PAP (mmHg) 32 (21 – 40) 46 (23 – 64) 38 (21 – 76) 42 (22 – 80)
 Diastolic PAP (mmHg) 14 (11 – 20) 20 (20 – 32) 13 (10 – 24) 17 (14 – 31)
 Mean PAP (mmHg) 26 (17 – 37) 32 (18 – 49) 31 (12 – 47) 38 (18 – 60)
 PVR (WU) 3.3 (1.1 – 6.1) 5.6 (2.2 – 10.4) 4.3 (1.5 –4.5) 7.6 (2.5 – 10.5)
 PVRi (WU x m2) 3.2 (1.4 – 6.5) 3.9 (3.7 – 18) 4.6 (1.7 – 12) 4.8 (2.7 – 20.7)
 PA compliance (ml/mmHg/m2) 1.5 (0.9–3.9) 1.5 (0.6–3.1) 1.1 (0.7 – 2.1) 1.4 (0.8–3.6)
DE derived values
 PAAT (msec) 88 (35 – 115) 69 40– 93) 76 (31– 141) 69 (41 –91)
 RVET (msec) 267 (216–345) 269 (207–302) 280 (210–356) 280 (218–306)
 PAAT:RVET 0.31 (0.20–0.50) 0.29 (0.20–0.37) 0.31 (0.19–0.46) 0.29 (0.22–0.36)
Data are expressed as mean (minimum and maximum range)
PAP, pulmonary artery pressure
PVR, pulmonary vascular resistance; WU, wood unit
PVRi, pulmonary vascular resistance index
PA compliance, pulmonary arterial compliance, (PA compliance = stroke volume / pulse pressure)
PAAT, pulmonary artery acceleration time
RVET, right ventricle ejection time
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